Debiopharm Group has successfully developed five products.
These products include :
Eloxatin®, Elplat® a DACH platin for the treatment of colorectal cancer
Decapeptyl®, Neo Decapeptyl®, Trelstar®, Pamorelin® 3-month formulation for the treatment of prostate cancer and in some countries for the treatment of endometriosis, precocious puberty, ovarian cancer, breast cancer, female infertility (in vitro fertilisation programmes)
Decapeptyl®, Trelstar®, Pamorelin® 6-month formulation for prostate cancer
Salvacyl®, Moapar® for the treatment of severe sexual deviations
Eloxatin® was awarded the prestigious Prix Galien in 2004. Both Eloxatin®, Elplat® and Decapeptyl®, Trelstar® have been among the top ranking products of Debiopharm’s commercial partners.
